We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Altus Power (AMPS) delivered earnings and revenue surprises of 0% and 3.90%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
Pacific Biosciences (PACB) delivered earnings and revenue surprises of 0% and 0.08%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
Beauty Health (SKIN) delivered earnings and revenue surprises of 28.57% and 1.59%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
Repay Holdings (RPAY) delivered earnings and revenue surprises of 4.55% and 0.60%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
Sharecare (SHCR) delivered earnings and revenue surprises of 0% and 12.47%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
Flux Power (FLUX) delivered earnings and revenue surprises of -45.45% and 9.76%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
Innospec (IOSP) delivered earnings and revenue surprises of 6.71% and 1.56%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
Cantaloupe (CTLP) delivered earnings and revenue surprises of 20% and 2.41%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
BioLife Solutions (BLFS) delivered earnings and revenue surprises of 26.92% and 8.28%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
Diodes (DIOD) delivered earnings and revenue surprises of 3.70% and 0.90%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
Inseego (INSG) delivered earnings and revenue surprises of 26.53% and 8.72%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
Guardant Health (GH) delivered earnings and revenue surprises of 36.11% and 11.94%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
Skillz (SKLZ) delivered earnings and revenue surprises of -16.94% and 14.56%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
ISG (III) delivered earnings and revenue surprises of -83.33% and 2.70%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
Silver Spike Investment (SSIC) delivered earnings and revenue surprises of -112.50% and 15.97%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
Integral Ad Science (IAS) delivered earnings and revenue surprises of 50% and 2.17%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
TechTarget (TTGT) delivered earnings and revenue surprises of 3.33% and 0.64%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
Fidelis Insurance (FIHL) delivered earnings and revenue surprises of -1.33% and 11.25%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
Navitas Semiconductor (NVTS) delivered earnings and revenue surprises of -50% and 0.11%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
Onto Innovation (ONTO) delivered earnings and revenue surprises of 7.27% and 2.86%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
Health Catalyst (HCAT) delivered earnings and revenue surprises of 66.67% and 0.11%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
JFrog (FROG) delivered earnings and revenue surprises of 14.29% and 1.70%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
AnaptysBio (ANAB) delivered earnings and revenue surprises of -6.49% and 57.78%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
Mettler-Toledo (MTD) delivered earnings and revenue surprises of 16.82% and 5.14%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
Ginkgo Bioworks (DNA) delivered earnings and revenue surprises of 0% and 16.60%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
industry-outlook: Archive
Altus Power, Inc. (AMPS) Reports Q1 Loss, Tops Revenue Estimates
by Zacks Equity Research
Altus Power (AMPS) delivered earnings and revenue surprises of 0% and 3.90%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
AMPSPositive Net Change PEDNegative Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Pacific Biosciences of California (PACB) Reports Q1 Loss, Tops Revenue Estimates
by Zacks Equity Research
Pacific Biosciences (PACB) delivered earnings and revenue surprises of 0% and 0.08%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
PACBPositive Net Change DRIOPositive Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
The Beauty Health Company (SKIN) Reports Q1 Loss, Tops Revenue Estimates
by Zacks Equity Research
Beauty Health (SKIN) delivered earnings and revenue surprises of 28.57% and 1.59%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
SKINPositive Net Change OCUPNegative Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Repay Holdings (RPAY) Q1 Earnings and Revenues Beat Estimates
by Zacks Equity Research
Repay Holdings (RPAY) delivered earnings and revenue surprises of 4.55% and 0.60%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
RPAYNegative Net Change PSFEPositive Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Sharecare, Inc. (SHCR) Reports Q1 Loss, Misses Revenue Estimates
by Zacks Equity Research
Sharecare (SHCR) delivered earnings and revenue surprises of 0% and 12.47%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
SHCRNegative Net Change SLGLPositive Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Flux Power Holdings, Inc. (FLUX) Reports Q3 Loss, Misses Revenue Estimates
by Zacks Equity Research
Flux Power (FLUX) delivered earnings and revenue surprises of -45.45% and 9.76%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
FLUXNegative Net Change GTECNegative Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Innospec (IOSP) Q1 Earnings Beat Estimates
by Zacks Equity Research
Innospec (IOSP) delivered earnings and revenue surprises of 6.71% and 1.56%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
IOSPNegative Net Change FSIPositive Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Cantaloupe (CTLP) Surpasses Q3 Earnings Estimates
by Zacks Equity Research
Cantaloupe (CTLP) delivered earnings and revenue surprises of 20% and 2.41%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
CTLPNegative Net Change NYAXPositive Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
BioLife Solutions, Inc. (BLFS) Reports Q1 Loss, Tops Revenue Estimates
by Zacks Equity Research
BioLife Solutions (BLFS) delivered earnings and revenue surprises of 26.92% and 8.28%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
BLFSPositive Net Change PBHNegative Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Diodes (DIOD) Surpasses Q1 Earnings Estimates
by Zacks Equity Research
Diodes (DIOD) delivered earnings and revenue surprises of 3.70% and 0.90%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
DIODPositive Net Change VEEVPositive Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Inseego (INSG) Reports Q1 Loss, Tops Revenue Estimates
by Zacks Equity Research
Inseego (INSG) delivered earnings and revenue surprises of 26.53% and 8.72%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
INSGPositive Net Change HCPPositive Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Guardant Health (GH) Reports Q1 Loss, Tops Revenue Estimates
by Zacks Equity Research
Guardant Health (GH) delivered earnings and revenue surprises of 36.11% and 11.94%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
GHPositive Net Change SPROPositive Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Skillz Inc. (SKLZ) Reports Q1 Loss, Lags Revenue Estimates
by Zacks Equity Research
Skillz (SKLZ) delivered earnings and revenue surprises of -16.94% and 14.56%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
SKLZPositive Net Change GESPositive Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Information Services Group (III) Q1 Earnings and Revenues Lag Estimates
by Zacks Equity Research
ISG (III) delivered earnings and revenue surprises of -83.33% and 2.70%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
IIINegative Net Change CPRTNegative Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Silver Spike Investment Corp. (SSIC) Reports Q1 Loss, Tops Revenue Estimates
by Zacks Equity Research
Silver Spike Investment (SSIC) delivered earnings and revenue surprises of -112.50% and 15.97%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
SSICPositive Net Change ICMBNegative Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Integral Ad Science (IAS) Reports Q1 Loss, Tops Revenue Estimates
by Zacks Equity Research
Integral Ad Science (IAS) delivered earnings and revenue surprises of 50% and 2.17%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
IASPositive Net Change GAMBNegative Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
TechTarget (TTGT) Beats Q1 Earnings and Revenue Estimates
by Zacks Equity Research
TechTarget (TTGT) delivered earnings and revenue surprises of 3.33% and 0.64%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
TTGTNegative Net Change MMYTPositive Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Fidelis Insurance Holdings (FIHL) Lags Q1 Earnings and Revenue Estimates
by Zacks Equity Research
Fidelis Insurance (FIHL) delivered earnings and revenue surprises of -1.33% and 11.25%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
FIHLNegative Net Change BNSPositive Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Navitas Semiconductor Corporation (NVTS) Reports Q1 Loss, Tops Revenue Estimates
by Zacks Equity Research
Navitas Semiconductor (NVTS) delivered earnings and revenue surprises of -50% and 0.11%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
NVTSNegative Net Change KAROPositive Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Onto Innovation (ONTO) Q1 Earnings and Revenues Top Estimates
by Zacks Equity Research
Onto Innovation (ONTO) delivered earnings and revenue surprises of 7.27% and 2.86%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
ONTONegative Net Change RDCMPositive Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Health Catalyst (HCAT) Q1 Earnings Beat Estimates
by Zacks Equity Research
Health Catalyst (HCAT) delivered earnings and revenue surprises of 66.67% and 0.11%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
HCATPositive Net Change AUGXPositive Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
JFrog Ltd. (FROG) Surpasses Q1 Earnings and Revenue Estimates
by Zacks Equity Research
JFrog (FROG) delivered earnings and revenue surprises of 14.29% and 1.70%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
FROGPositive Net Change BOXPositive Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
AnaptysBio, Inc. (ANAB) Reports Q1 Loss, Tops Revenue Estimates
by Zacks Equity Research
AnaptysBio (ANAB) delivered earnings and revenue surprises of -6.49% and 57.78%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
ANABPositive Net Change DCPHPositive Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Mettler-Toledo (MTD) Surpasses Q1 Earnings and Revenue Estimates
by Zacks Equity Research
Mettler-Toledo (MTD) delivered earnings and revenue surprises of 16.82% and 5.14%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
MTDNegative Net Change WKMEPositive Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Ginkgo Bioworks Holdings, Inc. (DNA) Reports Q1 Loss, Lags Revenue Estimates
by Zacks Equity Research
Ginkgo Bioworks (DNA) delivered earnings and revenue surprises of 0% and 16.60%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
DNAPositive Net Change FULCNegative Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank